Solvay Pharmaceuticals - European Neurological Disease 2007 Supplement
This supplement to our European Neurology journal which focuses on cutting-edge work in the field of advanced Parkinson's disease. Based on a one-day symposium organised by Solvay Pharmaceuticals, this supplement contains papers written by the eight distinguished speakers at the symposium as well as Q&A sessions with two of them. Topics covered include non-motor symptoms, deep-brain stimulation versus continuous dopaminergic infusion, issues with dopamine agonist therapy and long-term levodopa infusion.
